NeuroOne Medical Technologies: Assessing Cash Burn Rate and Growth Potential

NeuroOne Medical Technologies (NASDAQ:NMTC) has zero debt and cash worth $8.0m as of June 2025. Its cash burn was $4.1m last year, resulting in a cash runway of about 2.0 years. However, the company's growth rate is impressive, with revenue increasing by 69% and cash burn decreasing by 64% over the last year. The company is also well-positioned to raise more capital if needed.